[INTRODUCTION 1 PART I. 3 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THE COMPANY 30 ITEM 4A. UNRESOLVED STAFF COMMENTS 53 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 53 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 83 ITEM 7.] [Name of Company Country of Shareholding Principal Activities Shenzhen Mindray Bio-Medical Electronics Co., Ltd. PRC MR Investments (HK) Limited: 88.918828% MR Holdings (HK) Limited: 11.081086% Non-controlling interest:0.000087%* Manufacturing and sales of medical equipment, research and development of related products and investment holding Shenzhen Mindray Investment & Development Co., Ltd. PRC Shenzhen Mindray Bio-Medical Electronics Co., Ltd.:99% Nanjing Mindray Bio-Medical Electronics] [CERTIFICATION I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Cheng Minghe, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Alex Lung, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION Li Xiting Director, President and Co-Chief Executive Officer Cheng Minghe Co-Chief Executive Officer and Chief Strategic Officer Alex Lung Chief Financial Officer EX-13.1 6 d646003dex131.htm EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (No. 333-178896) We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 Hong Kong April 28, 2014 EX-23.1 7 d646003dex231.htm EX-23.1]